HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Saudi Arabia Microbial Transglutaminase Market Size & Outlook, 2025-2033


Saudi Arabia Microbial Transglutaminase Market Insights

  • As highlighted in Reed Intelligence analysis, the Saudi Arabia Microbial Transglutaminase Market, worth USD 3.49 Million in 2024, is forecasted to achieve USD 8.26 Million by 2033.
  • The Saudi Arabia market is anticipated to grow at a CAGR of 9.94% during the period 2026–2033.
  • By 2024, Streptomyces Mobaraense represented the largest share of the By Source market size.
  • Streptomyces Mobaraense is expected to remain the key growth driver within By Source, registering the fastest CAGR during the forecast period.

Other Key Findings


  • In 2024, Saudi Arabia accounted for 2.56% of the global Microbial Transglutaminase Market size.
  • By 2033, United States is expected to lead the global Microbial Transglutaminase Market in terms of market size.
  • Within Middle East and Africa, United Arab Emirates is projected to dominate the regional Microbial Transglutaminase Market size by 2033.
  • United Arab Emirates is identified as the fastest-growing market in Middle East and Africa, anticipated to reach USD 12.27 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 3.49 Million
Market Size In 2033 USD 8.26 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.94% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports